Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?

Affiliations

¹ Alba Fiorentino, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; and Filippo Alongi, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, and University of Brescia, Brescia, Italy.

Comment

Alba Fiorentino et al. J Clin Oncol. 2018.

. 2018 Aug 20;36(24):2558-2559.

doi: 10.1200/JCO.2018.78.1005. Epub 2018 Jun 26.

¹ Alba Fiorentino, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; and Filippo Alongi, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, and University of Brescia, Brescia, Italy.

No abstract available

Comment in

Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et al.
Rajyaguru DJ, Borgert AJ, Halfdanarson TR, Truty MJ, Kurup AN, Go RS. Rajyaguru DJ, et al. J Clin Oncol. 2018 Aug 20;36(24):2567-2569. doi: 10.1200/JCO.2018.78.6418. Epub 2018 Jun 26. J Clin Oncol. 2018. PMID: 29945519 No abstract available.

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.
Rajyaguru DJ, Borgert AJ, Smith AL, Thomes RM, Conway PD, Halfdanarson TR, Truty MJ, Kurup AN, Go RS. Rajyaguru DJ, et al. J Clin Oncol. 2018 Feb 20;36(6):600-608. doi: 10.1200/JCO.2017.75.3228. Epub 2018 Jan 12. J Clin Oncol. 2018. PMID: 29328861